Study Stopped
End of european funding
Alternative Treatments in Acute Mountain Sickness
TAIA
Can Osteopathy and Expiratory Resistance be Used in Prevention and/or Treatment of Acute Mountain Sickness ? a Randomized Controlled Field Study
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this research is to support a hypothesis that osteopathic manual medicine (OMM) and / or a 10 cmH2O end-expiratory pressure (PEEP) could be used in the prevention of acute mountain sickness (AMS). During altitude exposure, an exaggerated hypoxemia and the increase of intracranial pressure are both known to be major physipathological ways of AMS development. The goal of the osteopathic protocol is to release tension on the circulatory structures directly related to cranial circulation and drainage. The main hypothesis is that it could lead to lower intracranial pressure and help reducing AMS signs. Furthermore the investigators would like to define a osteopathic score for individual AMS sensitivity, based on cranial bones mobility. Several studies have shown that using PEEP at altitude (or hypoxia) increases SpO2. As for osteopathy protocol, the investigators would like to apply this experimental condition during real altitude exposure in a randomized controlled protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2016
CompletedStudy Start
First participant enrolled
June 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2018
CompletedFirst Posted
Study publicly available on registry
May 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2019
CompletedAugust 30, 2021
August 1, 2021
1.3 years
November 16, 2016
August 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Lake Louise Score from baseline to altitude continuous exposure.
Signs of acute mountain sickness regarding its severity according the official Lake Louise Score.
mesured and reported every hour during a 10 hours altitude exposure
Secondary Outcomes (1)
Changes in numeric scale of well being from baseline to altitude continuous exposure.
every hour during a 10 hours altitude exposure
Study Arms (3)
Osteopathic group
EXPERIMENTALLCS Drainage before altitude exposure
PEEP 10 cmH2O
EXPERIMENTAL10 min at rest
Control group
SHAM COMPARATORSham PEEP and fake osteopathic protocol
Interventions
Osteopathic intervention improving drainage of LCS and cerebral blood flow through opitmizing veinous circulation
Breathing through a 10 cmH2O expiratory resistance for 10 min every 2 hours during 10h at 3842m high
Eligibility Criteria
You may qualify if:
- Healthy
- Experienced alpinist
- No previous acclimatization
You may not qualify if:
- Heart failure, respiratory failure, kidney failure
- Pregnant woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ifremmont
Chamonix, 74400, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of research
Study Record Dates
First Submitted
November 16, 2016
First Posted
May 20, 2019
Study Start
June 17, 2017
Primary Completion
October 20, 2018
Study Completion
July 31, 2019
Last Updated
August 30, 2021
Record last verified: 2021-08